Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Aldehyde dehydrogenase 1 expression in cancer cells could have prognostic value for patients with non-small cell lung cancer who are treated with neoadjuvant therapy: identification of prognostic microenvironmental factors after chemoradiation.

Zenke Y, Ishii G, Ohe Y, Kaseda K, Yoshida T, Matsumoto S, Umemura S, Yoh K, Niho S, Goto K, Ohmatsu H, Kuwata T, Nagai K, Ochiai A.

Pathol Int. 2013 Dec;63(12):599-606. doi: 10.1111/pin.12122.

PMID:
24422956
2.

Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.

Shien K, Toyooka S, Ichimura K, Soh J, Furukawa M, Maki Y, Muraoka T, Tanaka N, Ueno T, Asano H, Tsukuda K, Yamane M, Oto T, Kiura K, Miyoshi S.

Lung Cancer. 2012 Jul;77(1):162-7. doi: 10.1016/j.lungcan.2012.02.006. Epub 2012 Mar 3.

PMID:
22387005
3.

Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.

You Q, Guo H, Xu D.

Drug Des Devel Ther. 2015 Sep 3;9:5087-97. doi: 10.2147/DDDT.S87197. eCollection 2015.

4.

Aldehyde dehydrogenase 1 expression is associated with poor prognosis in patients with esophageal squamous cell carcinoma.

Minato T, Yamamoto Y, Seike J, Yoshida T, Yamai H, Takechi H, Yuasa Y, Furukita Y, Goto M, Bando Y, Tangoku A.

Ann Surg Oncol. 2013 Jan;20(1):209-17. doi: 10.1245/s10434-012-2535-8. Epub 2012 Jul 31.

PMID:
22847125
5.

Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract.

Kitamura H, Torigoe T, Hirohashi Y, Asanuma H, Inoue R, Nishida S, Tanaka T, Fukuta F, Masumori N, Sato N, Tsukamoto T.

Mod Pathol. 2013 Jan;26(1):117-24. doi: 10.1038/modpathol.2012.139. Epub 2012 Aug 17.

6.

Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival.

Bueno R, Richards WG, Swanson SJ, Jaklitsch MT, Lukanich JM, Mentzer SJ, Sugarbaker DJ.

Ann Thorac Surg. 2000 Dec;70(6):1826-31.

PMID:
11156079
7.

Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer.

Mieog JS, de Kruijf EM, Bastiaannet E, Kuppen PJ, Sajet A, de Craen AJ, Smit VT, van de Velde CJ, Liefers GJ.

BMC Cancer. 2012 Jan 26;12:42. doi: 10.1186/1471-2407-12-42.

8.

ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy.

Deng Y, Zhou J, Fang L, Cai Y, Ke J, Xie X, Huang Y, Huang M, Wang J.

Br J Cancer. 2014 Jan 21;110(2):430-4. doi: 10.1038/bjc.2013.767. Epub 2013 Dec 10.

9.

HDGF and ADAM9 are novel molecular staging biomarkers, prognostic biomarkers and predictive biomarkers for adjuvant chemotherapy in surgically resected stage I non-small cell lung cancer.

Zhang J, Chen N, Qi J, Zhou B, Qiu X.

J Cancer Res Clin Oncol. 2014 Aug;140(8):1441-9. doi: 10.1007/s00432-014-1687-2. Epub 2014 Apr 27.

PMID:
24770635
10.

Aldehyde Dehydrogenase 1 Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemotherapy Prior to Radical Hysterectomy.

Xie Q, Liang J, Rao Q, Xie X, Li R, Liu Y, Zhou H, Han J, Yao T, Lin Z.

Ann Surg Oncol. 2016 Jan;23(1):163-70. doi: 10.1245/s10434-015-4555-7. Epub 2015 Apr 28.

PMID:
25916979
11.

Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications.

Rahadiani N, Ikeda J, Mamat S, Matsuzaki S, Ueda Y, Umehara R, Tian T, Wang Y, Enomoto T, Kimura T, Aozasa K, Morii E.

Cancer Sci. 2011 Apr;102(4):903-8. doi: 10.1111/j.1349-7006.2011.01864.x. Epub 2011 Feb 9.

12.

High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway.

Levallet G, Bergot E, Antoine M, Creveuil C, Santos AO, Beau-Faller M, de Fraipont F, Brambilla E, Levallet J, Morin F, Westeel V, Wislez M, Quoix E, Debieuvre D, Dubois F, Rouquette I, Pujol JL, Moro-Sibilot D, Camonis J, Zalcman G; Intergroupe Francophone de Cancérologie Thoracique (IFCT)..

Mol Cancer Ther. 2012 May;11(5):1203-13. doi: 10.1158/1535-7163.MCT-11-0899. Epub 2012 Mar 12.

13.

Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer.

Ohi Y, Umekita Y, Yoshioka T, Souda M, Rai Y, Sagara Y, Sagara Y, Sagara Y, Tanimoto A.

Histopathology. 2011 Oct;59(4):776-80. doi: 10.1111/j.1365-2559.2011.03884.x.

PMID:
22014057
14.

The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.

John T, Starmans MH, Chen YT, Russell PA, Barnett SA, White SC, Mitchell PL, Walkiewicz M, Azad A, Lambin P, Tsao MS, Deb S, Altorki N, Wright G, Knight S, Boutros PC, Cebon JS.

PLoS One. 2013 Jul 23;8(7):e67876. doi: 10.1371/journal.pone.0067876. Print 2013.

15.

The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors.

Vogler T, Kriegl L, Horst D, Engel J, Sagebiel S, Schäffauer AJ, Kirchner T, Jung A.

Exp Mol Pathol. 2012 Feb;92(1):111-7. doi: 10.1016/j.yexmp.2011.10.010. Epub 2011 Nov 10.

PMID:
22101256
16.

ALDH1 is a prognostic factor for patients treated with neoadjuvant chemoradiotherapy and radical resection for stage III rectal cancer.

Oh SY, Sohn SH, Yim H, Lee D, Suh KW, Kim YB.

J Surg Oncol. 2015 Feb;111(2):243-7. doi: 10.1002/jso.23792. Epub 2014 Sep 30.

PMID:
25270363
17.

Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.

Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L, Wang H, Liu Z, Su Y, Stass SA, Katz RL.

Mol Cancer Res. 2009 Mar;7(3):330-8. doi: 10.1158/1541-7786.MCR-08-0393. Epub 2009 Mar 10.

18.

Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.

Han H, Landreneau RJ, Santucci TS, Tung MY, Macherey RS, Shackney SE, Sturgis CD, Raab SS, Silverman JF.

Hum Pathol. 2002 Jan;33(1):105-10.

PMID:
11823980
19.

[The value of neuroendocrine markers for response to therapy and survival in patients with advanced non-small cell lung cancer].

Petrović M, Ilić N, Baskić D.

Srp Arh Celok Lek. 2010 Jan-Feb;138(1-2):37-42. Serbian.

20.

The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis.

Zhou C, Sun B.

Oral Oncol. 2014 Dec;50(12):1144-8. doi: 10.1016/j.oraloncology.2014.08.018. Epub 2014 Sep 26. Review.

PMID:
25264224

Supplemental Content

Support Center